Jill Clark

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. ncbi Testing women for human immunodeficiency virus infection: who, when, and how?
    Jill Clark
    Northrop Grumman Information Technology, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:507-17. 2008
  2. ncbi Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States
    Denise J Jamieson
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA 30341, USA
    Am J Obstet Gynecol 197:S26-32. 2007
  3. ncbi The missing link: documentation of recognized maternal human immunodeficiency virus infection in exposed infant birth records, 24 United States jurisdictions, 1999-2003
    Allan W Taylor
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S132-6. 2007
  4. ncbi Promising strategies for preventing perinatal HIV transmission: model programs from three states
    Jill Clark
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Matern Child Health J 10:367-73. 2006
  5. ncbi Updated estimates of healthcare utilization and costs among perinatally HIV-infected children
    Stephanie L Sansom
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 41:521-6. 2006
  6. ncbi An end to perinatal HIV: success in the US requires ongoing and innovative efforts that should expand globally
    Carolyn K Burr
    François Xavier Bagnoud Center, University of Medicine and Dentistry of New Jersey, Newark 07103, USA
    J Public Health Policy 28:249-60. 2007

Detail Information

Publications6

  1. ncbi Testing women for human immunodeficiency virus infection: who, when, and how?
    Jill Clark
    Northrop Grumman Information Technology, Atlanta, Georgia, USA
    Clin Obstet Gynecol 51:507-17. 2008
    ..These recommendations are described separately for general populations (including nonpregnant women) and for pregnant women and their infants...
  2. ncbi Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States
    Denise J Jamieson
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA 30341, USA
    Am J Obstet Gynecol 197:S26-32. 2007
    ..For women with HIV RNA levels of < 1000 copies/mL, a 3-part zidovudine prophylaxis regimen (prenatal, intrapartum, and neonatal) should be used alone or in combination with other antiretroviral drugs...
  3. ncbi The missing link: documentation of recognized maternal human immunodeficiency virus infection in exposed infant birth records, 24 United States jurisdictions, 1999-2003
    Allan W Taylor
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Am J Obstet Gynecol 197:S132-6. 2007
    ..1-2.6). Enhanced communication between pediatric and obstetric and gynecologic providers to eliminate this missed opportunity for prevention would improve HIV infection outcomes for HIV-exposed infants and improve care for their mothers...
  4. ncbi Promising strategies for preventing perinatal HIV transmission: model programs from three states
    Jill Clark
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Matern Child Health J 10:367-73. 2006
    ..Each of these strategies has been developed based on an in-depth assessment of the strengths and weaknesses of existing prevention approaches, and the needs of the populations they serve...
  5. ncbi Updated estimates of healthcare utilization and costs among perinatally HIV-infected children
    Stephanie L Sansom
    Epidemiology Branch, Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 41:521-6. 2006
    ..This study examined changes in healthcare use among perinatally HIV-infected children and developed new estimates of expected lifetime treatment costs...
  6. ncbi An end to perinatal HIV: success in the US requires ongoing and innovative efforts that should expand globally
    Carolyn K Burr
    François Xavier Bagnoud Center, University of Medicine and Dentistry of New Jersey, Newark 07103, USA
    J Public Health Policy 28:249-60. 2007
    ..Successful approaches that have nearly eliminated perinatal HIV transmission in the United States offer valuable lessons that should be applied to primary HIV prevention for women in the United States and globally...